Cumulative Corticosteroid Dose Over Fifty‐Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab Trials

Cumulative Corticosteroid Dose Over Fifty‐Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab Trials

Bibliographic Details
Main Authors: van Vollenhoven, Ronald F., Petri, Michelle, Wallace, Daniel J., Roth, David A., Molta, Charles T., Hammer, Anne E., Tang, Yongqiang, Thompson, April
Format: Online
Language:English
Published: John Wiley and Sons Inc. 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129492/
id pubmed-5129492
recordtype oai_dc
spelling pubmed-51294922016-11-30 Cumulative Corticosteroid Dose Over Fifty‐Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab Trials van Vollenhoven, Ronald F. Petri, Michelle Wallace, Daniel J. Roth, David A. Molta, Charles T. Hammer, Anne E. Tang, Yongqiang Thompson, April Systemic Lupus Erythematosus John Wiley and Sons Inc. 2016-08-25 2016-09 /pmc/articles/PMC5129492/ /pubmed/26992106 http://dx.doi.org/10.1002/art.39682 Text en © 2016 The Authors. Arthritis & Rheumatology published by Wiley Periodicals, Inc. on behalf of the American College of Rheumatology. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author van Vollenhoven, Ronald F.
Petri, Michelle
Wallace, Daniel J.
Roth, David A.
Molta, Charles T.
Hammer, Anne E.
Tang, Yongqiang
Thompson, April
spellingShingle van Vollenhoven, Ronald F.
Petri, Michelle
Wallace, Daniel J.
Roth, David A.
Molta, Charles T.
Hammer, Anne E.
Tang, Yongqiang
Thompson, April
Cumulative Corticosteroid Dose Over Fifty‐Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab Trials
author_facet van Vollenhoven, Ronald F.
Petri, Michelle
Wallace, Daniel J.
Roth, David A.
Molta, Charles T.
Hammer, Anne E.
Tang, Yongqiang
Thompson, April
author_sort van Vollenhoven, Ronald F.
title Cumulative Corticosteroid Dose Over Fifty‐Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab Trials
title_short Cumulative Corticosteroid Dose Over Fifty‐Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab Trials
title_full Cumulative Corticosteroid Dose Over Fifty‐Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab Trials
title_fullStr Cumulative Corticosteroid Dose Over Fifty‐Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab Trials
title_full_unstemmed Cumulative Corticosteroid Dose Over Fifty‐Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab Trials
title_sort cumulative corticosteroid dose over fifty‐two weeks in patients with systemic lupus erythematosus: pooled analyses from the phase iii belimumab trials
description
publisher John Wiley and Sons Inc.
publishDate 2016
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129492/
_version_ 1613747791378513920

Similar Items